EP1267970A1 — Inhaler
Assigned to AstraZeneca AB · Expires 2003-01-02 · 23y expired
What this patent protects
An inhaler for holding a canister ( 2 ) of medicament. The canister ( 2 ) has a mount ( 26 ) secured thereto mounting an indication member ( 41 ) movable slidably from a first state to a second state. A ratchet arrangement ( 41 a , 42 ) is provided between the mount ( 26 ) and th…
USPTO Abstract
An inhaler for holding a canister ( 2 ) of medicament. The canister ( 2 ) has a mount ( 26 ) secured thereto mounting an indication member ( 41 ) movable slidably from a first state to a second state. A ratchet arrangement ( 41 a , 42 ) is provided between the mount ( 26 ) and the indication member ( 41 ) to make the movement irreversible. The inhaler has a catch ( 49 ) for moving the indication member from the first state to the second state on removal of the canister ( 2 ) from the inhaler. An electrical switch contact ( 48 ) detects the state of the indication member ( 41 ), thereby providing an indication of whether the canister ( 2 ) has been used before. An LCD display is controlled in response to the detection.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.